the Efficacy and Safety of Sugammadex in Children 0-2 Years Old
Conditions: Anesthesia; Pediatric Cancer; Pediatric Tumor; Pediatric Hepatoblastoma; Beta-Thalassemia; Hepatic Metastases Intervention: Drug: Sugammadex Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy & Immunology | Anesthesia | Anesthesiology | Cancer | Cancer & Oncology | Children | Hematology | Hepatoblastoma | Pediatrics